Skip to main content
Clinical Trials/NCT06633861
NCT06633861CompletedNot Applicable

Data Collection Study for RFP (Respiration From Plethysmogram)

Philips Clinical & Medical Affairs Global1 site in 1 country86 target enrollmentStarted: September 5, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
86
Locations
1
Primary Endpoint
Data collection for database for algorithm development

Study Overview

Brief Summary

The study will be conducted in hospitalised patients who undergo spot-check monitoring of vital signs as part of their routine care.

Detailed Description

In an additional spot-check measurement procedure, the study will measure oxygen saturations through different Philips SpO2 finger sensors. Patients will wear a nasal cannula linked to a CO2 measuring device at the same time. The data from both devices will be used to design and improve algorithms for measurement of respiratory rate with the saturation probe and the Philips FAST pulse oximeter system. The study will include 50 adult patients and 25 pediatric patients.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
4 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult subjects (aged 18 years or older) willing and able to understand and provide written informed consent
  • •Paediatric subjects aged 16 years and older willing and able to understand and provide written informed consent
  • •Paediatric subjects aged approx. 4-16 years and their legal guardians, willing and able to understand and provide written informed consent/assent
  • •Subject weight within intended use of at least one SpO2 sensor under test at time of enrolment (M1191T: adult patients >50kg, M1196T: adult patients >40kg, M1192A: paediatric patients 15-50kg)
  • •Willing and able to wear study devices during study procedures
  • •Subject undergoing regular spot-check measurements as per the site's standard of care

Exclusion Criteria

  • •Palliative patients
  • •Critically ill patients with severe physiological instability (NEWS ≥9)
  • •Injury/wounds or physical malformation of sensor application site (i.e. fingers, toes, hands, feet)
  • •Subjects with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors (self-reported)
  • •Unwillingness or inability to remove coloured nail polish or artificial nails from application site
  • •Nail fungus on application site
  • •Severe dermatitis or hyperkeratosis (e.g. ichthyosis) at sensor application site

Arms & Interventions

In-patients with routine spot-check monitoring of vital signs

Experimental

In-patients with routine spot-check monitoring of vital signs

Intervention: spot-check measurement (Device)

Outcomes

Primary Outcomes

Data collection for database for algorithm development

Time Frame: 6 months

Anonymized database of subject data from the Oxygen Saturation finger sensors (photoplethysmogram waveform) and the reference sensors (capnography waveform)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials